Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High-dose carboplatin, thiotepa and cyclophosphamide (CTC) with peripheral blood stem cell support in the adjuvant therapy of high-risk breast cancer: a practical approach.
van der Wall E, Nooijen WJ, Baars JW, Holtkamp MJ, Schorangel JH, Richel DJ, Rutgers EJ, Slaper-Cortenbach IC, van der Schoot CE, Rodenhuis S. van der Wall E, et al. Among authors: nooijen wj. Br J Cancer. 1995 Apr;71(4):857-62. doi: 10.1038/bjc.1995.165. Br J Cancer. 1995. PMID: 7536025 Free PMC article. Clinical Trial.
Randomised trial of high-dose chemotherapy and haemopoietic progenitor-cell support in operable breast cancer with extensive axillary lymph-node involvement.
Rodenhuis S, Richel DJ, van der Wall E, Schornagel JH, Baars JW, Koning CC, Peterse JL, Borger JH, Nooijen WJ, Bakx R, Dalesio O, Rutgers E. Rodenhuis S, et al. Among authors: nooijen wj. Lancet. 1998 Aug 15;352(9127):515-21. doi: 10.1016/S0140-6736(98)01350-6. Lancet. 1998. PMID: 9716055 Clinical Trial.
Reinfusion of autologous lymphocytes with granulocyte-macrophage colony-stimulating factor induces rapid recovery of CD4+ and CD8+ T cells after high-dose chemotherapy for metastatic breast cancer.
de Gast GC, Vyth-Dreese FA, Nooijen W, van den Bogaard CJ, Sein J, Holtkamp MM, Linthorst GA, Baars JW, Schornagel JH, Rodenhuis S. de Gast GC, et al. J Clin Oncol. 2002 Jan 1;20(1):58-64. doi: 10.1200/JCO.2002.20.1.58. J Clin Oncol. 2002. PMID: 11773154 Clinical Trial.
Immunotherapy with concurrent subcutaneous GM-CSF, low-dose IL-2 and IFN-alpha in patients with progressive metastatic renal cell carcinoma.
Verra N, Jansen R, Groenewegen G, Mallo H, Kersten MJ, Bex A, Vyth-Dreese FA, Sein J, van de Kasteele W, Nooijen WJ, de Waal M, Horenblas S, de Gast GC. Verra N, et al. Among authors: nooijen wj. Br J Cancer. 2003 May 6;88(9):1346-51. doi: 10.1038/sj.bjc.6600915. Br J Cancer. 2003. PMID: 12778059 Free PMC article. Clinical Trial.
53 results